TCG
SEM

Transcendent Capital Group’s Select Medical SEM Stock Holding History

Transcendent Capital Group’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,856
Closed -$35.1K – 501
2024
Q2 		$35.1K Buy
+1,856
New +$31.7K 0.02% 217

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Transcendent Capital Group's SEM Position: Q3 2024 in Review

Transcendent Capital Group sold out of Select Medical (SEM) in Q3 2024, closing a stake of 1,856 shares — an estimated $35.1K sold.

Transcendent Capital Group first reported a position in SEM in Q2 2024 and held it in 1 quarter. The position peaked at $35.1K in Q2 2024. 286 funds tracked by Wall St. Rank hold SEM as of Q3 2024.

  • Transcendent Capital Group reported no remaining Select Medical position as of Q3 2024 after selling out during the quarter.
  • Transcendent Capital Group sold 1,856 Select Medical shares in Q3 2024, an estimated $35.1K.
  • Transcendent Capital Group first reported a position in Select Medical in Q2 2024 and held it in 1 quarter.
  • Transcendent Capital Group's Select Medical position peaked at $35.1K in Q2 2024.
  • 286 funds tracked by Wall St. Rank held Select Medical as of Q3 2024.

Based on Transcendent Capital Group's 13F filing for Q3 2024, filed 1 Nov 2024.